Literature DB >> 24122644

Staged interventional management of a massive thrombus related to coronary artery ectasia in acute coronary syndrome.

Makoto Furugen1, Yoshitoki Takagawa.   

Abstract

Coronary artery ectasia (CAE), which is reported in 0.3-5.3% of coronary angiograms, is known as a risk factor of acute coronary syndrome (ACS). Optimal treatment of CAE in ACS has not yet been established because of few clinical reports and no randomized trial. We describe a 78-year-old woman in whom thrombolysis with recombinant tissue-plasminogen activator, heparin and dual antiplatelet therapy were performed, and an angiogram after 3 days revealed the disappearance of massive thrombus in the CAE of the left circumflex coronary artery. Staged percutaneous coronary intervention and multidisciplinary procedure are feasible to treat ACS with massive thrombus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 24122644     DOI: 10.1007/s12928-011-0083-y

Source DB:  PubMed          Journal:  Cardiovasc Interv Ther        ISSN: 1868-4297


  3 in total

Review 1.  Is Anticoagulant Necessary in Patients with Coronary Artery Ectasia Presenting with Acute Coronary Syndrome? A Systematic Review of Case Reports.

Authors:  Raymond Pranata; Emir Yonas; Veresa Chintya; Amir Aziz Alkatiri
Journal:  Int J Angiol       Date:  2019-06-28

2.  Recurrent acute coronary syndrome in a patient with right coronary artery ectasia: a case report.

Authors:  Vito Damay; Raymond Pranata; Wendy Wiharja
Journal:  J Med Case Rep       Date:  2019-03-09

3.  One-Year Outcome of Patients with Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks.

Authors:  Alireza Amirzadegan; Seyed-Ali Sadre-Bafghi; Saeed Ghodsi; Hamidreza Soleimani; Mehrnaz Mohebi; Ebrahim Nematipour; Ali-Mohammad Haji-Zeinali; Mojtaba Salarifar; Hamidreza Pourhosseini; Yones Nozari; Masih Tajdini; Hassan Aghajani; Mohammad Alidoosti; Yaser Jenab; Negar Omidi; Arash Jalali; Zahra Hosseini
Journal:  J Tehran Heart Cent       Date:  2020-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.